BIRC5 and ovarian benign neoplasm: A total of eleven studies [11, 16–23, 25, 26] reported the survivin expression in ovarian cancer vs ovarian benign tumor, with 528 cases of ovarian cancer patients and 262 ovarian benign tumor patients.